Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months
Clinical trial NCT05832333 · COMPLETED
Trial details
- NCT number
- NCT05832333
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-05
- Primary completion
- 2022-02-07
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.